Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy

FHS
July 11, 2023
11:31 am

NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumors, today announced it has been awarded £1.6M in grant funding from Innovate UK’s New Cancer Therapeutics program.

Mental Health Dominates Telehealth; Top Psychiatrist Sued; College PTSD Doubles

In 2021, 43.2% of visits to psychiatrists occurred by telehealth versus 4.5% of visits to other physicians. (Annals of Internal Medicine) One in three U.S.

June 6, 2024

MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results – Biotech Investments

EQS-News: MorphoSys AG / Key word(s): Half Year Report MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results 09.08.2023 / 22:01 CET/CEST The

August 10, 2023

Study reveals how DNA damage caused by chromosomal instability increases cancer invasiveness

Chromosomal instability is a phenomenon characterized by rapid changes in the number and structure of chromosomes during cell division.

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.